MAPT and supranuclear palsy, progressive, 1: Because of this heterogeneous phenotype, definitive diagnosis of PSP can only be confirmed at autopsy by the pathological presentation of neurodegeneration and specific hyperphosphorylated, four‐repeat (4R) Tau in neurons, and glia in anatomical regions corresponding to primary clinical symptoms (Kovacs et al., 2020).